Sale!

OncoDx Panel NGS Genetic Test

Original price was: 6,000 د.إ.Current price is: 4,400 د.إ.

-27%

The OncoDx Panel NGS (Next-Generation Sequencing) Genetic Test is a sophisticated diagnostic tool designed to provide comprehensive insights into the genetic mutations associated with various cancers. Offered at DNA Labs UAE, this cutting-edge test utilizes the latest in sequencing technology to analyze multiple genes simultaneously, helping in the identification of specific mutations that may influence cancer development, progression, and response to treatment.

With a focus on precision medicine, the OncoDx Panel aids oncologists in tailoring treatment plans to the individual genetic profile of a patient’s tumor, potentially improving outcomes and minimizing unnecessary treatments. It covers a wide range of cancer types, offering valuable information for both solid tumors and hematological malignancies.

The test is priced at 4400 AED, reflecting the advanced technology and expertise required to conduct such a comprehensive genetic analysis. By choosing to undergo the OncoDx Panel NGS Genetic Test at DNA Labs UAE, patients and their healthcare providers are taking a significant step towards a more personalized approach to cancer care, leveraging genetic insights to make informed decisions about treatment strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

OncoDx Panel NGS Genetic Test

Cost: 4400.0 AED

Test Name: OncoDx panel NGS Genetic DNA Test

Components Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cancer

Doctor: Oncologist

Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for OncoDx panel NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with APC, ATM, BARD1, BLM, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDK4, CDKN2A, CHEK2, EPCAM, FH, FLCN, HNF1A, HNF1B, HOXB13, MC1R, MEN1, MET, MITF, MLH1, MRE11A, MSH2, MSH6, MUTYH, NBN, NTHL1, PALB2, PMS1, PMS2, POLD1, POLE, POT1, PRSS1, PTCH1, PTEN, RAD50, RAD51C, RAD51D, RET, SDHA, SDHAF2, SDHB, SDHC, SDHD, SMAD4, STK11, TP53, TSC1, TSC2, VHL, WT1, XRCC2, XRCC3

Test Details:

The OncoDx panel is a next-generation sequencing (NGS) genetic DNA test that analyzes a panel of genes associated with cancer. This test is designed to help identify genetic mutations that may be driving the growth and spread of cancer, and to guide treatment decisions.

The OncoDx panel includes genes that are commonly mutated in various types of cancer, including breast, lung, colon, and prostate cancer. The test uses NGS technology to sequence the DNA of these genes, looking for mutations or other genetic alterations that may be contributing to cancer growth.

The results of the OncoDx panel test can help doctors tailor treatment plans to the specific genetic profile of a patient’s cancer. For example, if a patient has a mutation in a gene that is known to respond to a certain type of drug, that drug may be included in their treatment plan.

Overall, the OncoDx panel is a powerful tool for personalized cancer care, helping doctors to make more informed treatment decisions and improve outcomes for patients.

 

Test NameOncoDx panel NGS Genetic DNA Test
Components 
Price4400.0 AED
Sample ConditionBlood or Extracted DNA or One drop Blood on FTA Card
Report Delivery3 to 4 Weeks
MethodNGS Technology
Test typeCancer
DoctorOncologist
Test Department:Genetics
Pre Test InformationClinical History of Patient who is going for OncoDx panel NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with APC, ATM, BARD1, BLM, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDK4, CDKN2A, CHEK2, EPCAM, FH, FLCN, HNF1A, HNF1B, HOXB13, MC1R, MEN1, MET, MITF, MLH1, MRE11A, MSH2, MSH6, MUTYH, NBN, NTHL1, PALB2, PMS1, PMS2, POLD1, POLE, POT1, PRSS1, PTCH1, PTEN, RAD50, RAD51C, RAD51D, RET, SDHA, SDHAF2, SDHB, SDHC, SDHD, SMAD4, STK11, TP53, TSC1, TSC2, VHL, WT1, XRCC2, XRCC3
Test Details

The OncoDx panel is a next-generation sequencing (NGS) genetic DNA test that analyzes a panel of genes associated with cancer. This test is designed to help identify genetic mutations that may be driving the growth and spread of cancer, and to guide treatment decisions.

The OncoDx panel includes genes that are commonly mutated in various types of cancer, including breast, lung, colon, and prostate cancer. The test uses NGS technology to sequence the DNA of these genes, looking for mutations or other genetic alterations that may be contributing to cancer growth.

The results of the OncoDx panel test can help doctors tailor treatment plans to the specific genetic profile of a patient’s cancer. For example, if a patient has a mutation in a gene that is known to respond to a certain type of drug, that drug may be included in their treatment plan.

Overall, the OncoDx panel is a powerful tool for personalized cancer care, helping doctors to make more informed treatment decisions and improve outcomes for patients.